Sernova says five diabetes patients have now been taken off insulin after 'cell pouch' therapy
Five patients with type 1 diabetes have stopped taking insulin after getting Sernova’s cell transplant treatment, the Canadian biotech reported Monday morning. It’s the latest data on a delivery approach for a potential one-time treatment for type 1 diabetes, though it comes with some significant limitations.
In a Phase I/II study being conducted at the University of Chicago, Sernova said that the first five patients on the trial have now been insulin-independent for at least 6 months. The first patient on the trial has been insulin-independent for just over three years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.